Atlas Trials

Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma

Clinical trial NCT02056756 · COMPLETED

Trial details

NCT number
NCT02056756
Sponsor
Stichting European Myeloma Network
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2014-04-01
Primary completion
2015-09-01
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.